A total number of embryos used for hESC lines and overall outcomes
Human embryonic stem cell (hESC) lines, which are derived from inner cell mass (ICM) of supernumerary blastocysts-stage embryos, have well known unique properties; long-term self-renewing ability with maintenance of an undifferentiated state and pluripotent capacity to differentiate into all derivatives of three embryonic germ layers (Hoffman & Carpenter, 2005; Semb, 2005; Trounson, 2006). Since its first derivation and characterization by Thomson et al in 1998, these intrinsic properties have made hESC very popular worldwide and, thereby, many studies describing isolation and characterization of new hESC lines have been reported (Findikli et al., 2005; Simon et al., 2005; Thomson, 1998). HESCs have been considered very valuable and promising cell source for research involving mainly human embryogenesis, oncology, drug toxicology and developmental biology as well as for cell based regenerative therapies (Edwards, 2004).
Obviously, studies on hESCs mostly focus on their potential use for treatment of degenerative human diseases. However, due to the largely unknown characteristics of established lines and the use of animal based material in their cultures, most of the lines could not be suitable for prospective transplantation studies (Findikli et al., 2006; Rodriguez et al., 2006). Therefore, registration of existing hESC lines with their characteristics in stem cell banks would provide database of cell lines, cooperation and co-regulation for researchers.
In this chapter, it was aimed to report the methods to derive 18 hESC lines which were established and characterized until the declaration of prohibition on hESC research in Turkey by Health Ministry in 2005. Additionally, it was discussed the current legal situation of hESC research and perspectives to that issue in Turkey.
2. Material and methods for derivation and characterization of hESC lines
Derivation and characterization of all hESC lines were undertaken in Memorial Hospital ART &Reproductive Genetics Centre, R&D Laboratory, Istanbul, Turkey between January 2003 and September 2005. All donated supernumerary embryos were used after obtaining written informed consents from couples. All hESC lines were established only for research purpose rather than for any financial interest. This study was approved and controlled by the local ethic committee/Internal Review Board of Istanbul Memorial Hospital.
2.1. Source of supernumerary human embryos
Supernumerary human embryos used for derivation of hESC lines were obtained after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD) cycles. Most of these embryos had poor quality and thereby, were considered insufficient for replacement or cryopreservation.
Preimplantation genetic diagnosis is applied to three groups of patients with variety of indications in our clinic. The first group of PGD includes patients who have a high risk of transmitting their single gene disorder to their offspring. After diagnosis, abnormal embryos were used to derive hESC lines with specific single gene mutation.
In the second group of PGD cycles, embryos belonging to couples with advanced maternal age, a history of recurrent miscarriages and repeated implantation failures are destined to chromosomal screening (Kahraman et al., 2000, 2006; Lavon et al., 2008; Munne et al., 2005; Verlinsky et al., 2005). Following PGD, chromosomally abnormal embryos were subjected to derivation of hESC lines having chromosomal aneuploidies.
In the third group, PGD is used for identification of embryos for human leukocyte antigen (HLA) matching to an affected older sibling who requires hematopoietic stem cell transplantation. Furthermore, the HLA matching can be combined with mutational analysis for genetic diseases in cases where the sibling is affected with this monogenic disorder and waiting for stem cell transplantation. Therefore, in those cases, embryos having mismatched HLA type or carrying genetic disorder were used for derivation of hESC lines.
2.2. Isolation and preparation of feeder cells
As feeder cells both mouse embryonic fibroblast (MEF) and human foreskin fibroblast (HFF) were used during isolation and long term culture of hESC lines. MEFs were isolated from embryos of the 12- to 14-day pregnant BALb/c mice (Conner, 2000). To isolate single cell suspension of MEF mouse embryos isolated from the sacrificed mice by cervical dislocation were dissociated into small pieces with scissor. Then dissociated tissues were trypsinized in 0.25% trypsin-EDTA (Gibco BRL; Invitrogen, Gaithersburg, MD, USA) for 15min to produce single cell suspension.
Human foreskin fibroblasts were isolated from circumcised tissues of 0-1 year old males. Cell isolation was performed as described previously (Hovatta et al., 2003; Richard et al., 2002). In a brief, following the isolation of dermis from the epidermis by scissor or razor blade, tissue was dissected into small pieces and then trypsinized in 0.05% trypsin-EDTA (Gibco BRL) for approximately 1 h to dissociate into single cells.
Both 25 cm2 and 75 cm2 culture flasks were used to culture HFF and MEF lines. These lines were grown in feeder cell culture medium, consisting of 85% high glucose DMEM (Gibco BRL), 10%FBS (Gibco BRL), 1% penicillin streptomycin-amphotericin (Biological Industries) and 2mM L-glutamine (Gibco BRL) at 37C with 5% CO2. Supportive medium was changed in every three days. MEF lines could be used in culture of hESC lines up to 6 passages, whereas HFFs had supportive potential up to 15 passages.
Mitotic inactivation of feeder cells was performed after exposing feeder cells to culture medium containing 10µg/ml mitomycin C (Sigma-Aldrich, Poole, Dorset, UK) for 2.5-3h. Inactivated cells were seeded on a 0.1% gelatin-coated at a concentration of 1.5 105 cells / ml. After 2 days incubation organ culture dishes were ready to use as feeder plates. Feeder plates could be used for the following 7 d.
2.3. Isolation and long-term culture of hESC lines
Blastocyst stage embryos, that were graded according to the Gardner’s scoring criteria, were processed for hESC isolation by either immunosurgery or direct culture (Gardner et al., 2000; Findikli et al., 2005). Prior to the immunosurgery or direct culture, zona pellucida of embryo was removed by the short-term exposure to the 5IU/ml (final conc.) pronase (Sigma) containing embryo culture medium for up to 5 min. Immunosurgery was applied based on the previously published protocol (Solter and Knowles, 1975). After lysis of trophoblastic cells, the resulted intact inner cell mass clumps were placed on feeder cells and cultured until to observe the primary hESC colonies.
In the direct culture method, zona free blastocysts were directly placed on feeder cells and cultured until the appearance of outgrowth, which lasted about 6 to 8 days. Then compacted outgrowths including cells of hESC-like morphology were mechanically split into small clumps. The cell clumps were transferred on new feeder plates. The primary colonies were generally observed after about 5 to 7 days (Figure 1 A-B).
HESC lines were cultured at 37 C in 5% CO2 in the complete stem cell medium (CSCM) with the composition of 85% Ko-DMEM ( Gibco BRL), 15% FBS (Hyclone, South, Logan, UT, USA), 1 penicillin/streptomycin/amphotericin B (Biological Industries, Haemek, Israel), 1 non essential amino acid stock solution (Sigma), 0.1% 2mM L Glutamine (Gibco
BRL), 4ng/ml basic fibroblast growth factor (bFGF) (Chemicon, Temecula, CA, USA), β-mercaptoethanol (0.1 mmol/l; Sigma), and 0.1% insulin transferrin selenium complex (Gibco BRL). Culture media was changed daily.
Undifferentiated hESC colonies were split into small colony pieces mechanically with the flame-drawn glass every after 7-8 days of culture. Enzymatic dissociation of hESC was not preferred in this study. Each hESC line was cultured at least up to fifteen passages and was cryopreserved by vitrification technique according to the previously reported protocols (Reubinof et al., 2001; Vanderzwalmen et al., 2003). Briefly, colonies were first mechanically split into small pieces and were sequentially vitrified in two solutions including different concentration of DMSO and ethylene glycol.
Cryopreserved hESC lines were warmed sequentially in solutions including 0.5M and 0.25M sucrose to control efficiency of vitrification and following warming techniques (Reubinoff et al., 2001).
2.4. Karyotyping and immunocytochemistry of hESC lines
G-banding technique was used to karyotype hESC lines. HESC colonies were first incubated with culture medium including 0.1 µg / ml Colcemid (Biological Industries) for 2 h at 37 °C in a %5 CO2. Then colonies were split into small pieces mechanically and incubated in 0.075M KCI hypotonic solution for 17 minutes at 37°C. Colonies were fixed with methanol-acetic acid solution (3:1) and processed for G-banding analysis. For each line at least 20 metaphases were analyzed for confirmation.
Karyotyping of each line was performed several times to assess whether karyotypes were stable during their long term culture. Confirmation of genetic mutation in hESC line derived from affected embryo was performed by the same procedures applied for single blastomere mutational analysis.
Surface expression markers (SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81), which are unique for undifferentiated hESC lines, were immunochytoemically analyzed according to the manufacturer’s instructions (Chemicon) by using flourescein isothiocyanate (FITC)-conjugated goat anti-mouse secondary antibody (anti-IgG) (Santa Cruz Biotechnology, California, USA). Negative controls were performed by addition of phosphate buffer saline instead of the primary antibody. All the other reagents were the same as in the slides run for specific antibodies, except nucleus of cells were stained by 4',6-diamidino-2-phenylindole (DAPI) for visualization.
Alkaline phosphatase activity (Chemicon) of hESC lines was detected by using the Chemicon Alkaline Phophatase Detection kit (Chemicon). Expressions of OCT-4 and housekeeping gene, glyceraldehyde-3 phosphate dehydrogenase (GADPH), genes were detected by reverse transcriptase PCR (RT-PCR). Briefly, extraction of RNA from undifferentiated hESCs and synthesis of cDNA were carried out by using Rneasy Mini Kit (Qiagen Gmbh, Strasse, Germany) and Sensiscript RT Kit (Qiagen), respectively. Then, PCR and following analysis were performed according to the protocol of Amit et al (Amit et al., 2002).
2.5. Differentiation potential of hESC lines
The differentiation ability of hESC lines were analyzed only by
Differentiation features of hESC lines was examined under phase contrast microscope and differentiated cells were analyzed by immunocytochemical staining with markers for endoderm (cytokeratin 18, specific marker for epithelial cells, Chemicon), mesoderm (troponin I, specific for cardiac muscle; Chemicon) and ectoderm (Nestin, specific marker for progenitor of neuron, and MAP2AB, specific marker for mature neuron; Chemicon) according to manufacturer’s instruction.
Additionally, in these lines (OZ, OZ-1 and OZ-2), rhythmically beating of cardiomyocytes within spontaneously differentiating embryonic stem cells were further analyzed by transmission electron microscopy (TEM). Briefly, cell clumps with spontaneous contractions were gently removed from the culture plate and fixed in 2% glutaraldehyde in 0.1 mol/sodium cacodylate buffer (pH 7.4) for 2 hours. Secondary fixation was performed in 1% OsO4 in the same buffer for 1.5h. The grids were dehydrated in graded ethanol and embedded in Epon 812. The very thin sections about 80 nm were cut and stained with lead citrate for 8 min in order to identify the cellular structures of cardiac muscle cells.
3. Results of hESC study
Experience of hESC from Memorial Hospital comprise three phrases; derivation of first hESC lines in Turkey, which was reported previously (Findikli et al., 2005), using HFF as a feeder cell instead of MEF to derive new hESC lines and derivation of hESC lines from donated embryos from PGD cycles (Candan & Kahraman, 2010).
In the first phase, nine hESC lines, which were named NS-1, NS-2, NS-3, NS-4, NS-5, NS-6, NS-7, NS-8 and MINE, were derived from 26 donated blastocysts stage human embryos with a 34.6% success rate (Table 1). Twenty blastocysts were spare IVF/ICSI embryos and 5 hESC lines (NS-1, NS-2, NS-3, NS-4 and MINE) were derived from these embryos. The remaining 6 embryos had mismatched HLA type and, therefore were not eligible for transferring in PGD cycle. From these embryos, 4 hESC lines (NS-5, NS-6, NS-7 and NS-8)
|No.of blastocysts||No. of stem cell line, n, (%)||Names of derived hESC lines|
|IVF/ICSI embryos||30||8, (27)||NS-1,2,3,8, MINE, and OZ, OZ-1, OZ-2|
|PGD for single gene disorder||8||1, (13)||OZ-8|
|PGD for single gene disorder & HLA typing||6||4, (67)||*NS-4, 5, 6, and 7|
|PGD for chromosomal screening||42||7, (17)||OZ-3, OZ-4, OZ-5, OZ-6, OZ-7, NS-9, NS-10|
|Immunosurgery method||15||4, (27)||NS-1,2,3,4|
|Direct culture method||76||16, (21)|
were derived. Four lines (NS-1, NS-2, NS-3, NS-4) out of 9 hESC lines were obtained by immunosurgey and remaining 5 lines were derived by direct culture (Table 1). Two cell lines (NS-1 and NS-2) were spontaneous differentiated during their first days of
In the second phase of hESC research in Istanbul Memorial Hospital, as an alternative to MEF, HFF was used as a feeder cell for establishment and long-term culture of new hESC lines. Three hESC lines (OZ, OZ-1 and OZ-2) were derived from 10 blastocyst stage spare IVF/ICSI embryos by the direct culture technique with a 30% success rate (Table 1). Unlike to circular colony morphology of hESC colonies on MEF, hESC colonies on HFF had angular shaped morphology, due to the polarity of HFF cells (Figure 1 C-D).
In the final phase, following PGD, embryos diagnosed as having chromosomal abnormalities and single gene mutations were used to establish hESC lines (Table 1). Forty two blastocysts with different chromosomal aneuploidies were directly placed either on MEF or on HFF. From those embryos 7 hESC lines (OZ-3, OZ-4, OZ-5, OZ-6, OZ-7, NS-9 and NS-10) were derived (Table 1 and 2). Of these 7 hESC lines, one line (OZ-3) was derived from biopsied embryo whose diagnosis was suspicious. Although chromosomal content of biopsied blastomere from this embryo was identified as abnormal (trisomy 15) by FISH, because of the fragmentations in nuclear structure of blastomere, we could not interpret the result exactly and thereby assumed it as an abnormal (Candan & Kahraman, 2010).
Three embryos diagnosed as carrying cystic fibrosis and 5 embryos with beta-thalassemia were used to isolate hESC lines with genetic disorder. However, only one hESC (OZ-8), which had a single gene mutation causing beta-thalassemia, was isolated successfully. Only 4 hESC lines were isolated by immunosurgery and the remaining hESC lines were derived after direct culture of blastocysts on feeder cells (Table 2). Following to either direct culture or immunosurgery, the developing three dimensional outgrowths from ICM were split mechanically into small clumps and transferred onto new feeder plate. Duration for successful derivation of first primary hESC colonies was ranged 15 to 20 days, based on the quality of inner cell mass of blastocysts, and application of isolation techniques properly.
Following the first several passages of primary hESC colonies, flat colonies of cells with a distinguishable compacted colony structure, well defined colony border and cellular morphology with higher nucleus to cytoplasm ratio and prominent nucleoli were obtained (Figure 1 C-D). Regardless of type of feeder cells, these unique colony features were similar in all hESC. Each of hESC lines were passaged mechanically every after about 7-8d for more than 15 passages (Table 2). While passaging hESC colonies, spontaneously differentiated cells, which were observed frequently in the central or in the periphery part of colonies, were always removed mechanically to maintain undifferentiation state of colonies.
3.1. Unique features of hESC lines
All hESC lines were characterized for cell surface expression markers, which are unique to undifferentiated human embryonic stem cells. As shown in Figure 2A, established hESC lines represented a high level of alkaline phosphates activity. Furthermore, immunocytochemical staining revealed that derived 18 hESC lines were positive for SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81 (Figure 2B). Negative control slides of immunocytochemical staining showed that primary antibodies specifically bound to the certain surface antigens (Figure 2C).
|PGD/PGS results||-||-||HLA mismatched||HLA mismatched||HLA mismatched||HLA mismatched||Tetraploid||Monosomy-13||-|
|In vitro differentiation||+||+||+||+||+||+||+||+||+|
|Max. passage no. of lines||35||60||39||20||22||22||21||28||49|
|Karyotype||46 XY||46 XX||46 XX||46 XY||46 XX||46 XX||46 XY||46 XX||46XX|
|PGD/PGS results||-||-||-||Undiagnosed embryo||Trisomy 21||Monosomy15+ Trisomy 21||Monosomy|
|Type of feeder cell||HFF||HFF||HFF||HFF||HFF||HFF||MEF||MEF||MEF|
|In vitro differentiation||+||+||+||+||+||+||+||+||+|
|Max. passage no. of lines||19||15||15||22||17||20||22||18||18|
|Karyotype||46 XY||46 XX||46 XX||46 XX||46 XX||46 XY||46 XX||46 XY||46 XX|
Our hESC lines were not analyzed for SSEA-1 expression, a specific marker for mouse embryonic stem cells. In consistent with the previous reports, expression intensity of SSEA-3 among hESC lines was variable and comparably weaker than SSEA-4 which was consistent and expressed higher in all hESC lines (Oh et al., 2005). Additionally, OCT-4 expressions were higher in all undifferentiated hESC lines when compared to expression level of housekeeping gene GADPH (Figure 2D).
Testing differentiation capacity of each hESC line by embryoid body formation
Rhythmically contractions in cell clusters were started approximately after ten days from plating EBs on bacterial culture plates and kept continuing up to six weeks. During this period, beating cell clusters, belonging to OZ, OZ-1 and OZ-2 hESC lines, were further analyzed by transmission electron microscopy. Thereby, sarcomere, intercalated disc and myofibril structures were well defined in cardiac muscle cells by TEM analysis (Figure 3E).
Following vitrification and thawing procedures, all cell lines could retain their unique properties; long-term extension and pluripotency capacity
3.2. Karyotyping and genetic analysis of hESC lines
Karyotyping analysis of all hESC lines were performed at the 5th passages. HESC lines, which were derived from supernumerary embryos after IVF/ICSI cycles and from PGD embryos, having genetic disorder and/or having mismatched HLA, had normal karyotypes (Figure 2E and Table 2).
HESC lines derived from chromosomally abnormal embryos were first analyzed by FISH at 1st passage whether they had detected chromosomal abnormality. Surprisingly, chromosomal abnormalities were not confirmed in these lines. Contrarily, analyzed chromosomes were euploid in number. Further confirmation was performed by karyotyping at 5th passages of these lines. In consistent with results after FISH at 1st passage, karyotyping analysis revealed that in contrast to the diagnosis after PGD their karyotypes were normal (Table 2).
Karyotyping of all hESC lines were performed further passages whether cell lines retained normal karyotypes. All hESC lines had stable karyotypes.
Mutation in OZ-8 hESC cell line with beta thalassemia disorder was confirmed by PCR and subsequent sequencing procedures at passage 6. The homozygote single nucleotide transition (guanine to adenine nucleotide transition) in second exon of beta-globin gene was detected.
Human embryonic stem cell is one of the most contradictory scientific issues since it was first reported by Thomson in 1998. Obviously, this ongoing dispute has been arisen from the use of human embryo for derivation of hESC. In regard to that concern, alternative methods have been proposed by several researches. However, spare embryos generated for reproductive and therapeutic treatments still remain as a main source for hESC derivation. Therefore, registering all existing lines in a database, like stem cell bank, may decrease the necessities to derive new hESC lines worldwide and eventually ethical concern may be alleviated among the public. In that regard, all these hESC lines, which had been established and characterized in Istanbul Memorial Hospital until ruling on ban on hESC research by Turkish Health Ministry, were registered to European hESCreg in 2008.
During the hESC derivation study, 86 donated embryos, which were considered insufficient for transfer and cryopreservation after IVF/ICSI cycles and were diagnosed as having genetic disorder or chromosomal aneuploidies and having mismatched HLA type after PGD cycles, were used.
The derivation efficiency of hESC lines was 20% and success rate was directly related with the quality of blastocysts. Four (NS-1, NS-2, NS-3 and NS-4) out of 20 hESC lines were successfully derived from 15 blastocysts after immunosurgery. However, two of these lines were spontaneously differentiated at the early number of passages. Remaining 16 hESC lines were isolated through direct culture of whole blastocysts on feeder cells. These two methods had comparable success rates (27% vs 21%,
All lines described in this chapter had similar colony and cellular morphology. These lines expressed unique cell surface expression markers, including SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81. They also had high level of alkaline phosphatase activity and expressed OCT-4 gene, which keeps pluripotency of hESC lines during long-term culture (Figure 2). Moreover, these 18 hESC lines were proven to have pluripotent capacity
Although all lines were capable of differentiating into derivatives of three embryonic germ layers, differentiating characteristic was varied among lines. The prevalence of differentiating cardiomyocytes was higher in EBs generated from OZ-3 line, whereas higher percentage of neuron-like cells were observed in EBs generated from OZ line. The presence of specific cell lines at a various degree in differentiating cell cultures of hESC lines may be attributed to the developmental stage of embryo used for derivation, genomic and epigenetic differences.
In PGD for chromosomal screening cycles, embryos diagnosed as having chromosomal abnormalities were likely to be discarded and not to be considered eligible for transfer. In consistent with the previous results, in which it was aimed to derive chromosomally abnormal hESC lines for investigation of various aspects of early embryonic development, all our hESC lines derived from those embryos had normal karyotypes (Munne et al., 2005; Lavon et al., 2008). As stated in these studies, this unexpected result has been suggested to self correction of embryos during long-term
As a result of proposed mosaicism and trisomy rescue mechanisms in developing embryos, chromosomal self correction may be occurred. In the mosaic embryos, it was suggested that euploid blastomeres can grow preferentially to abnormal cells during early embryogenesis or alternatively, these normal cells were preferentially allocated to the inner cell mass. Therefore, embryo may be subject to self correction mechanism and may evolve to a fetus with euploid chromosomal number. In trisomic rescue mechanism, it has been speculated that embryos can be corrected in terms of chromosomal number through anaphase-lag, nondisjunction, or chromosomal demolition. However, these mechanisms are still assumptions and exacts mechanisms should be proven by further studies (Hazan et al., 2008).
Furthermore, we speculated that the long-term culture may not only induce the change in chromosomal content but also may result in various genetic or epigenetic modifications in hESC lines which could eventually impair their pluripotent and self renewal capacity. However, due to inured restriction on hESC research, these derived lines could not be analyzed regarding to these aspects (Candan et al 2010).
Embryos, having single gene mutations, are of great importance, while considering as a potential source in genetic based researches on understanding the mechanisms of disease and developing new drugs (Pickering et al., 2003; Verlinsky et al., 2005). We derived one hESC line having mutation, that cause beta thalassemia disorder, from 5 donated embryos after PGD. This cell line can provide as a cell source to study the pathology of beta thalassemia and its effects on different cell types.
HESC researches have been increasing continuously since it was first isolated and characterized. Although several problems including derivation clinical grade hESC lines, risk for teratoma formation, HLA incompatibility of cells and establishment of well defined differentiation protocols of hESC lines to certain cell types have been not been solved efficiently, there is still hope for coming day in which hESC lines will be used effectively in cell replacement therapies to treat such devastating human diseases; myocardial infarcts, spinal cord injuries and diabetes. Therefore, hESC lines reported in this chapter could be potential cell source for
In this chapter, it is aimed to summarized establishment protocols and features of first reported hESC lines in Turkey. Turkey is among the countries in which earlier hESC studies were established first. Today, however, Turkey is one of the countries in which hESC researches were prohibited by Government. Unfortunately, so far new legislation or regulation has not been declared. However, establishment of new guideline is on the agenda of governmental institutions nowadays. Recent lifting of ban on the federal funding for hESC research in US and given permission on first clinical trial of hESC may, in fact, affect the political opinion and hopefully may inure regulations, which resume hESC researches under the control of authority and new guidelines in Turkey.
We would like to specifically thank to Necati Findikli, Oya Akcin and Ayla Eker Sariboyaci for their previous contributions on the derivation and characterization of hESC lines and all IVF staff for their kindly help in human embryo culture and support. Additionally, we are very thankful to all Genetic laboratory staff for PGD analysis and karyotyping all hESC lines. Study was supported and funded by Istanbul Memorial Hospital.
Amit M. Margulets V. Segev H. 2002Human feeder layers for human embryonic stem cells. 68 2150 2156
Candan N. Z. Kahraman S. 2010Establishment and characterization of human embryonic stem cell lines, Turkey perspectives. , 46 345 355
Carpenter M. K. Rosler E. Rao M. S. 2003Characterization and differentiation of human embryonic stem cells. Cloning and Stem Cells, 5 79 88
Conner D. A. 2000Mouse embryo fibroblast (MEF) feeder cell preparation. Current Protocols in Molecular Biology, 23.2. 1 23
Edwards R. G. 2004Stem cells today: A. Origin and potential of embryo stem cells. Reproductive BioMedicine Online, 8 275 306
Findikli N. Kahraman S. Akcin O. 2005Isolation and characterization of new human embryonic stem cell lines. 10 617 627
Findikli N. Candan Z. N. Kahraman S. 2006Human embryonic stem cell culture: current limitations and novel strategies. 13 581 590
Gardner D. K. Lane M. Stevens J. 2000Blastocyst score affects implantation and pregnancy outcome: towards a single embryo transfer. , 73 1155 1158
BS Hazan Frumkin. T. Malcov M. 2008Preimplantation aneuploid embryos undergo self-correction in correlation with their developmental potential. 92 890 896
Hoffman L. M. Carpenter M. K. 2005Characterization and culture of human embryonic stem cells. Nature Biotechnology, 23 699 708
Hovatta O. Mokkola M. Gertow K. 2003A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. , 18 1404 1409
Itskovitz-Eldor J. Schuldiner M. Karsenti D. 2000Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers, 6(2), 88 EOF 95 EOF
Kahraman S. Bahce M. Samli H. 2000Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure. 15 2003 2007
Kahraman S. Findikli N. Biricik A. 2006Preliminary FISH studies on spermatozoa and embryos in patients with variable degrees of teratozoospermia and a history of poor prognosis. 12 752 761
Lavon N. Narwani K. Golan-Lev T. et al. 2008Derivation of euploid human embryonic stem cells from aneuploid embryos, Stem Cells 26 1874 1882
Munne S. Velilla E. Colls P. 2005Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. 84 1328 1334
Oh K. S. Kim H. S. Ahn J. H. 2005Derivation and Characterization of New Human Embryonic Stem Cell Lines: SNUhES1, SNUhES2, and SNUhES3. Stem Cells, 23 211 219
Pickering S. J. Braude P. R. Patel M. 2003Preimplantation genetic diagnosis as a novel source of embryos for stem cell research. 7 353 364
Reubinoff B. E. Pera M. F. Vajta G. Trounson A. O. 2001Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. , 16 2187 2194
Richards M. Fong C. Y. Chan W. K. 2002Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. 20 933 936
Rodriguez C. I. Galan A. Valbuena D. 2006Derivation of clinical grade human embryonic stem cells. 12 112 118
Semb H. 2005Human embryonic stem cells: origin, properties and applications. 113 743 750
Simon C. Escobedo C. Valbuena D. 2005First derivation in Spain of human embryonic stem cell lines: use of long-term cryopreserved embryos and animal-free conditions. 83 246 249
Solter D. Knowles B. B. 1975Immunosurgery of mouse blastocyst. , 72 5099 5102
Thomson J. A. Itskovitz-Eldor J. Shapiro S. S. 1998Embryonic stem cell lines derived from human blastocysts 282 1145 1147
Trounson A. 2006The production and directed differentiation of human embryonic stem cells. 27 208 219
Van de Stolpe A. van de Brink S. van Rooijen M. 2005Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell line. 11 476 485
Vanderzwalmen P. Bertin G. Debauche Ch. 2003Vitrification of human blastocysts with the Hemi-Straw carrier: application of assisted hatching after thawing. , 18 1504 1511
Verlinsky Y. Strelchenko N. Kukharenko V. 2005Human embryonic stem cell lines with genetic disorders. 10 105 110